NAT10 and myocardial infarction: Furthermore, immunohistochemistry (IHC) and dot blotting analyses demonstrated that the inhibition of NAT10 resulted in the suppression of myocardial infarction (MI)‐induced upregulation of ac4C acetylation, while NAT10 expression remained unaffected (Figure 4B–D).